(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.04%) $0.791
(0.86%) $85.73
0.00% HKD 8.60
Live Chart Being Loaded With Signals
Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists...
Stats | |
---|---|
Tagesvolumen | 3 000 |
Durchschnittsvolumen | 71 966 |
Marktkapitalisierung | 928.80M |
EPS | HKD0.230 ( Q4 | 2023-12-31 ) |
Last Dividend | HKD0.499 ( 2023-06-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E |
16.86 (Sector) 14.27 (Industry) 0 |
ATR14 | HKD0 (0.00%) |
Charmacy Pharmaceutical Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Charmacy Pharmaceutical Finanzdaten
Annual | 2023 |
Umsatz: | HKD4.40B |
Bruttogewinn: | HKD292.74M (6.65 %) |
EPS: | HKD0.480 |
FY | 2023 |
Umsatz: | HKD4.40B |
Bruttogewinn: | HKD292.74M (6.65 %) |
EPS: | HKD0.480 |
FY | 2022 |
Umsatz: | HKD4.18B |
Bruttogewinn: | HKD268.61M (6.43 %) |
EPS: | HKD0.840 |
FY | 2021 |
Umsatz: | HKD3.79B |
Bruttogewinn: | HKD237.22M (6.25 %) |
EPS: | HKD0.221 |
Financial Reports:
No articles found.
Charmacy Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.949 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.229 | 2016-11-14 |
Last Dividend | HKD0.499 | 2023-06-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 9 | -- |
Total Paid Out | HKD2.57 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.88 | -- |
Div. Sustainability Score | 5.24 | |
Div.Growth Potential Score | 3.37 | |
Div. Directional Score | 4.30 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
29 Jun 2023 | HKD0.499 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
02 Jun 2023 | HKD0.450 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
02 Jun 2021 | HKD0.242 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
27 May 2020 | HKD0.219 | 31 Mar 2020 | 28 May 2020 | 10 Jul 2020 |
05 Jun 2019 | HKD0.341 | 26 Mar 2019 | 06 Jun 2019 | 08 Jul 2019 |
30 May 2018 | HKD0.246 | 22 Mar 2018 | 31 May 2018 | 03 Jul 2018 |
15 Nov 2017 | HKD0.118 | 24 Aug 2017 | 16 Nov 2017 | 15 Dec 2017 |
13 Jun 2017 | HKD0.229 | 22 Mar 2017 | 14 Jun 2017 | 17 Jul 2017 |
14 Nov 2016 | HKD0.229 | 22 Aug 2016 | 15 Nov 2016 | 15 Dec 2016 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3968.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
0921.HK | Ex Dividend Knight | 2023-07-10 | Sporadic | 0 | 0.00% | |
2199.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% | |
0518.HK | Ex Dividend Junior | 2023-09-01 | Sporadic | 0 | 0.00% | |
1709.HK | Ex Dividend Junior | 2023-09-13 | Annually | 0 | 0.00% | |
0103.HK | Ex Dividend Junior | 2023-07-14 | Sporadic | 0 | 0.00% | |
8092.HK | Ex Dividend Junior | 2023-08-14 | Sporadic | 0 | 0.00% | |
1171.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
2682.HK | Ex Dividend Junior | 2023-09-04 | Annually | 0 | 0.00% | |
0719.HK | Ex Dividend Knight | 2023-07-07 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0117 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0158 | 1.200 | 9.47 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0877 | 1.500 | -0.136 | -0.205 | [0.1 - 1] |
payoutRatioTTM | 1.470 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.074 | 0.800 | 9.63 | 7.71 | [1 - 3] |
quickRatioTTM | 0.615 | 0.800 | -1.089 | -0.871 | [0.8 - 2.5] |
cashRatioTTM | 0.242 | 1.500 | 9.77 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.481 | -1.500 | 1.987 | -2.98 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.894 | 2.00 | -0.298 | -0.596 | [0 - 30] |
freeCashFlowPerShareTTM | -1.272 | 2.00 | -0.636 | -1.272 | [0 - 20] |
debtEquityRatioTTM | 2.61 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0655 | 1.000 | -2.24 | -2.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0246 | 1.000 | -1.508 | -1.508 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.0618 | 1.000 | -1.455 | -1.455 | [0.2 - 2] |
assetTurnoverTTM | 1.356 | 0.800 | 4.29 | 3.43 | [0.5 - 2] |
Total Score | 5.24 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 16.83 | 1.000 | 8.40 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0877 | 2.50 | -0.0877 | -0.205 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.272 | 2.00 | -0.424 | -1.272 | [0 - 30] |
dividendYielPercentageTTM | 4.12 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.894 | 2.00 | -0.298 | -0.596 | [0 - 30] |
payoutRatioTTM | 1.470 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 2.95 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0219 | 1.000 | -3.05 | 0 | [0.1 - 0.5] |
Total Score | 3.37 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Charmacy Pharmaceutical
Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.